167 related articles for article (PubMed ID: 35848121)
1. PDCD10 promotes proliferation, migration, and invasion of osteosarcoma by inhibiting apoptosis and activating EMT pathway.
Xu K; Fei W; Huo Z; Wang S; Li Y; Yang G; Hong Y
Cancer Med; 2023 Jan; 12(2):1673-1684. PubMed ID: 35848121
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
3. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
4. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
5. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S.
Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y
J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209
[TBL] [Abstract][Full Text] [Related]
7. USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches.
Zhang Q; Zhu J; Xie J; Gu Y; Chen L
PeerJ; 2024; 12():e17397. PubMed ID: 38784391
[TBL] [Abstract][Full Text] [Related]
8. LncRNA GSEC promotes the proliferation, migration and invasion by sponging miR-588/ EIF5A2 axis in osteosarcoma.
Liu R; Ju C; Zhang F; Tang X; Yan J; Sun J; Lv B; Guo Y; Liang Y; Lv XB; Zhang Z
Biochem Biophys Res Commun; 2020 Nov; 532(2):300-307. PubMed ID: 32868080
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
10. ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.
Li S; Xue J; Zhang H; Shang G
J Orthop Surg Res; 2023 Nov; 18(1):910. PubMed ID: 38031136
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
12. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP.
Wang Y; Huang H; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1458-1465. PubMed ID: 31007083
[TBL] [Abstract][Full Text] [Related]
13. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
14. Hydroxygenkwanin suppresses proliferation, invasion and migration of osteosarcoma cells via the miR‑320a/SOX9 axis.
Dong X; Wang Y; Zhuang H; An G
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929504
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis.
Guo W; Jiang H; Li H; Li F; Yu Q; Liu Y; Jiang W; Zhang M
Technol Cancer Res Treat; 2019 Jan; 18():1533033819841438. PubMed ID: 31106680
[TBL] [Abstract][Full Text] [Related]
16. PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling.
Liu J; Wang J; Tian W; Xu Y; Li R; Zhao K; You C; Zhu Y; Bartsch JW; Niu H; Zhang H; Shu K; Lei T
Aging (Albany NY); 2022 Aug; 14(15):6066-6080. PubMed ID: 35963638
[TBL] [Abstract][Full Text] [Related]
17. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
[TBL] [Abstract][Full Text] [Related]
19. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
[TBL] [Abstract][Full Text] [Related]
20. PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway.
Fang L; Wang B; Yang Z; Zhao T; Hao W
Sci Rep; 2023 Dec; 13(1):21827. PubMed ID: 38071381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
